Cargando…

Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report

BACKGROUND: Collecting duct carcinoma (CDC) of the kidney is a rare and highly aggressive malignant tumor with the worst prognosis among all renal cancers. Nevertheless, the first-line treatments, including chemotherapy and target therapy, usually show poor response to CDC. Recent studies have sugge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Yongyi, Zhang, Wei, Li, Zhenli, Zheng, Youshi, Wang, Yingchao, Chen, Geng, Qiu, Liman, Ke, Kun, Su, Xiaoping, Cai, Zhixiong, Liu, Jingfeng, Liu, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247377/ https://www.ncbi.nlm.nih.gov/pubmed/32439798 http://dx.doi.org/10.1136/jitc-2019-000217

Ejemplares similares

Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns
por: Li, Zhenli, et al.
Publicado: (2021)

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
por: Cai, Zhixiong, et al.
Publicado: (2021)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
por: Zhang, Da, et al.
Publicado: (2021)

Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
por: Wu, Ming, et al.
Publicado: (2023)

Circular RNA profiling identifies circADAMTS13 as a miR‐484 sponge which suppresses cell proliferation in hepatocellular carcinoma
por: Qiu, Liman, et al.
Publicado: (2019)

Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models
por: Chen, Hengkai, et al.
Publicado: (2022)

Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
por: Wang, Yunhao, et al.
Publicado: (2022)

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model
por: Liao, Naishun, et al.
Publicado: (2020)

Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion
por: Liao, Naishun, et al.
Publicado: (2019)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
por: Zhao, Bixing, et al.
Publicado: (2019)

Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
por: Liao, Naishun, et al.
Publicado: (2017)

Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma
por: Dong, Xiuqing, et al.
Publicado: (2022)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
por: Cai, Yu, et al.
Publicado: (2023)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
por: Truex, Nicholas L., et al.
Publicado: (2020)

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
por: Brito Baleeiro, Renato, et al.
Publicado: (2023)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2023)

Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC)
por: Chen, Geng, et al.
Publicado: (2023)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)

Identifying neoantigens for use in immunotherapy
por: Hutchison, Sharon, et al.
Publicado: (2018)

Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021)

Groundwork for AI: Enforcing a benchmark for neoantigen prediction in personalized cancer immunotherapy
por: Jaton, Florian
Publicado: (2023)

Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p
por: Chen, Feng, et al.
Publicado: (2021)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

Cancer neoantigens as potential targets for immunotherapy
por: Ma, Weijie, et al.
Publicado: (2021)

The Value of Microbes in Cancer Neoantigen Immunotherapy
por: Tian, Junrui, et al.
Publicado: (2023)

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

Personalized cancer neoantigen vaccines come of age
por: Chu, Yanhong, et al.
Publicado: (2018)

Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis
por: Zhao, Bixing, et al.
Publicado: (2019)

Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma
por: Lin, Zhiwen, et al.
Publicado: (2023)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mi4bms3rlfoth81rqsd6509td